Each Ampoule (4ml) contains Citicoline 500 mg as Citicoline Sodium INN.
It is indicated in the treatment of Alzheimer's disease and other types of dementia, head trauma, amblyopia, cerebrovascular disease such as ischaemic stroke, age-related memory loss, Parkinson's disease, attention deficit-hyperactive disorder (ADHD) and glaucoma
Each Ampoule (4ml) contains Citicoline 500 mg as Citicoline Sodium INN.
It is indicated in the treatment of Alzheimer's disease and other types of dementia, head trauma, amblyopia, cerebrovascular disease such as ischaemic stroke, age-related memory loss, Parkinson's disease, attention deficit-hyperactive disorder (ADHD) and glaucoma
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.